Modulations in the ATPases during ketamine-induced schizophrenia and regulatory effect of “3-(3, 4-dimethoxy phenyl) -1- (4-methoxyphenyl) prop-2-en-1-one”: anin vivoandin silicostudies
- 2 February 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 40 (2) , 148-156
Abstract
Schizophrenia is a devastating illness and displays a wide range of psychotic symptoms. Accumulating evidence indicate impairment of bioenergetic pathways including energy storage and usage in the pathogenesis of schizophrenia. Although well-established synthetic drugs are being used for the management of schizophrenia, most of them have several adverse effects. Hence, natural products derived from medicinal plants represent a continuous major source for ethnomedicine-derived pharmaceuticals for different neurological disorders including schizophrenia. In the present study, we have investigated the neuroprotective effect of the novel bioactive compound i.e. “3-(3,4-dimethoxy phenyl) -1- (4-methoxyphenyl) prop-2-en-1-one” of Celastrus paniculata against ketamine-induced schizophrenia with particular reference to the activities of ATPase using in vivo and in silico methods. Ketamine-induced schizophrenia caused significant reduction in the activities of all three ATPases (Na+/K+, Ca2+ and Mg2+) in different regions of brain which reflects the decreased turnover of ATP, presumably due to the inhibition of oxidoreductase system and uncoupling of the same from the electron transport system. On par with the reference compound, clozapine, the activity levels of all three ATPases were restored to normal after pretreatment with the compound suggesting recovery of energy loss that was occurred during ketamine-induced schizophrenia. Besides, the compound has shown strong interaction and exhibited highest binding energies against all the three ATPases with a lowest inhibition constant value than the clozapine. The results of the present study clearly imply that the compound exhibit significant neuroprotective and antischizophrenic effect by modulating bioenergietic pathways that were altered during induced schizophrenia.Keywords
This publication has 53 references indexed in Scilit:
- Effects of lithium therapy on Na+–K+-ATPase activity and lipid peroxidation in bipolar disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2012
- MK-801 alters Na+, K+-ATPase activity and oxidative status in zebrafish brain: reversal by antipsychotic drugsJournal of Neural Transmission, 2011
- Mitochondrial dysfunction and pathology in bipolar disorder and schizophreniaInternational Journal of Developmental Neuroscience, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Na,K-ATPase Activity Regulates AMPA Receptor Turnover through Proteasome-Mediated ProteolysisJournal of Neuroscience, 2009
- Mitochondrial involvement in psychiatric disordersAnnals of Medicine, 2008
- A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophreniaIndian Journal of Psychiatry, 2008
- Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stressMolecular Psychiatry, 2004
- MEMBRANE Na ´ +;-K ´ +; ATPase MEDIATED CASCADE IN BIPOLAR MOOD DISORDER, MAJOR DEPRESSIVE DISORDER, AND SCHIZOPHRENIA RELATIONSHIP TO HEMISPHERIC DOMINANCEInternational Journal of Neuroscience, 2002
- Neonatal Status Convulsivus, Spongiform Encephalopathy, and Low Activity of Na+/K+ ‐ATPase in the BrainEpilepsia, 1992